ALB and neoplasm: The tumor growth inhibition curve for mice treated with such albumin-based NPs was similar to that of Abraxane, showing significant tumor growth inhibition efficacy with, respectively, 97.5% and 93.7% reduction of the tumor volume on day 21 [104].